Get the Stockscreener App
1.11
11.20%
-0.14
Alzamend Neuro Inc Stock (ALZN) Forecast
The Alzamend Neuro Inc (ALZN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.1141, representing a +0.37% increase from the current price of $1.11. The highest analyst price target is $1.1342, and the lowest is $1.0941.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ALZN Price Target
Average 0.8823
(-20.51% Downside)
Is Alzamend Neuro Inc (ALZN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 34.54 | Neutral |
| STOCH(9,6) | 53.67 | Neutral |
| STOCHRSI(14) | 40.79 | Neutral |
| MACD(12,26) | -0.0657 | Buy |
| ADX(14) | 16.54 | Neutral |
| William %R | -82.14 | Buy |
| CCI(14) | -67.37 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.216
Sell
|
1.2118
Sell
|
| MA20 |
1.2305
Sell
|
1.252
Sell
|
| MA50 |
1.4254
Sell
|
1.4686
Sell
|
| MA100 |
1.8379
Sell
|
2.1312
Sell
|
| MA200 |
4.1356
Sell
|
3.4298
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ALZN could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on ALZN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 34.54 indicates that ALZN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 53.67 indicates that ALZN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 40.79 indicates that ALZN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.54 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -67.37 indicates that ALZN is still oversold but not to an extreme extent.
Long-term ALZN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Alzamend Neuro Inc financial reports and earnings history, Alzamend Neuro Inc (ALZN) stock could reach $1.8139 by 2030, $12.43 by 2040 and $19.99 by 2050. See the projected annual prices until 2050 of the Alzamend Neuro Inc stock below:
- Alzamend Neuro Inc (ALZN) is expected to reach an average price of $6.2223 in 2035, with a high prediction of $6.6673 and a low estimate of $6.3623. This indicates an $460.56% rise from the last recorded price of $1.11.
- Alzamend Neuro Inc (ALZN) stock is projected to chart a bullish course in 2040, with an average price target of $13.09, representing an $1,079% surge from its current level. The forecast ranges from a conservative $2.2161 to a sky-high $12.43.
- Our analysts predict Alzamend Neuro Inc (ALZN) to jump 784.51% by 2045, soaring from $9.9451 to an average price of $9.818, potentially reaching $9.9607. While $9.9451 is the low estimate, the potential upside is significant.
- Alzamend Neuro Inc (ALZN) stock is expected to climb by 2050, reaching an average of $19.85, a $1,688% jump from its current level. However, a wide range of estimates exists, with high and low targets of $19.99 and $19.91, respectively, highlighting the market's uncertainty.
Alzamend Neuro Inc Stock (ALZN) Year by Year Forecast
Alzamend Neuro Inc Stock (ALZN) Price Forecast for 2025
Alzamend Neuro Inc Stock (ALZN) is expected to reach an average price of $0.8823 in 2025, with a high prediction of $1.1653 and a low estimate of $0.5994. This indicates an -20.51% fall from the last recorded price of $1.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.0241 | $1.0941 | $1.1342 | -7.74% |
| February, 2025 | $1.2966 | $1.0807 | $1.0506 | +16.81% |
| March, 2025 | $1.2321 | $1.2339 | $1.155 | +11.00% |
| April, 2025 | $1.2061 | $1.184 | $1.1653 | +8.66% |
| May, 2025 | $1.0464 | $1.1768 | $1.1531 | -5.73% |
| June, 2025 | $1.0134 | $1.0975 | $1.0657 | -8.71% |
| July, 2025 | $0.9565 | $0.9561 | $0.9477 | -13.83% |
| August, 2025 | $0.6631 | $0.8031 | $0.7932 | -40.26% |
| September, 2025 | $0.6696 | $0.6697 | $0.6196 | -39.68% |
| October, 2025 | $0.5028 | $0.6128 | $0.6595 | -54.71% |
| November, 2025 | $0.8397 | $0.5994 | $0.5793 | -24.35% |
| December, 2025 | $1.0286 | $1.035 | $1.0386 | -7.34% |
Alzamend Neuro Inc Stock (ALZN) Price Forecast for 2026
The predicted value for Alzamend Neuro Inc (ALZN) in 2026 is set at an average of $0.532. Estimates vary from a peak of $1.0344 to a trough of $0.0295, indicating an -52.07% surge from the present price of $1.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.9489 | $0.9124 | $0.8854 | -14.51% |
| February, 2026 | $0.9455 | $0.9802 | $0.9799 | -14.82% |
| March, 2026 | $1.0271 | $0.9922 | $1.004 | -7.47% |
| April, 2026 | $0.8716 | $0.862 | $0.8907 | -21.47% |
| May, 2026 | $0.6056 | $0.6918 | $0.8319 | -45.44% |
| June, 2026 | $0.7132 | $0.6023 | $0.5717 | -35.75% |
| July, 2026 | $0.738 | $0.7433 | $0.7166 | -33.52% |
| August, 2026 | $0.8765 | $0.7481 | $0.778 | -21.04% |
| September, 2026 | $0.8512 | $0.8456 | $0.8446 | -23.32% |
| October, 2026 | $0.8317 | $0.8367 | $0.8127 | -25.07% |
| November, 2026 | $0.9358 | $0.5008 | $1.0344 | -15.70% |
| December, 2026 | $0.2026 | $0.0295 | $1.0291 | -81.75% |
Alzamend Neuro Inc Stock (ALZN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Alzamend Neuro Inc (ALZN) is $1.5208, with a high forecast of $3.039 and a low forecast of $0.00263. This indicates an +37.01% increase from the last price of $1.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0261 | $0.00263 | $0.246 | -97.65% |
| February, 2027 | $0.000462 | $0.0319 | $0.1601 | -99.96% |
| March, 2027 | $0.1523 | $0.0427 | $0.223 | -86.28% |
| April, 2027 | $0.2398 | $0.1497 | $0.5865 | -78.39% |
| May, 2027 | $0.2133 | $0.2118 | $0.4249 | -80.78% |
| June, 2027 | $2.044 | $0.0283 | $1.384 | +84.14% |
| July, 2027 | $2.2871 | $2.2973 | $2.1138 | +106.04% |
| August, 2027 | $2.2574 | $2.4503 | $2.6559 | +103.37% |
| September, 2027 | $3.0415 | $2.6334 | $2.8365 | +174.01% |
| October, 2027 | $2.7995 | $2.9763 | $2.7063 | +152.21% |
| November, 2027 | $2.5126 | $2.7226 | $2.8861 | +126.36% |
| December, 2027 | $3.3089 | $2.8859 | $3.039 | +198.10% |
Alzamend Neuro Inc Stock (ALZN) Price Forecast for 2028
In 2028, Alzamend Neuro Inc (ALZN) is projected to reach an average price of $2.8903, with a high projection of $3.4618 and a low estimate of $2.3188. This indicates an +160.39% rise from the last price of $1.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.322 | $3.3355 | $3.2255 | +199.28% |
| February, 2028 | $3.4651 | $3.4253 | $3.4618 | +212.17% |
| March, 2028 | $3.3214 | $3.3214 | $3.4283 | +199.22% |
| April, 2028 | $3.3545 | $3.4279 | $3.2745 | +202.20% |
| May, 2028 | $3.2993 | $3.3108 | $3.3022 | +197.23% |
| June, 2028 | $3.1876 | $3.2439 | $3.2456 | +187.17% |
| July, 2028 | $3.0969 | $3.1169 | $3.1933 | +179.00% |
| August, 2028 | $2.8733 | $2.9028 | $3.0525 | +158.85% |
| September, 2028 | $2.7463 | $2.864 | $2.8543 | +147.42% |
| October, 2028 | $2.2894 | $2.5094 | $2.4696 | +106.25% |
| November, 2028 | $2.5057 | $2.4525 | $2.426 | +125.74% |
| December, 2028 | $2.2888 | $2.3188 | $2.419 | +106.20% |
Alzamend Neuro Inc Stock (ALZN) Price Forecast for 2029
The 2029 price forecast for Alzamend Neuro Inc Stock (ALZN) is $2.2632 on average, with a high prediction of $2.6778 and a low estimate of $1.8487. This represents an +103.89% increase from the previous price of $1.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.7402 | $2.3178 | $2.6551 | +146.87% |
| February, 2029 | $2.5382 | $2.5982 | $2.6778 | +128.67% |
| March, 2029 | $2.5213 | $2.4847 | $2.4713 | +127.14% |
| April, 2029 | $2.4833 | $2.4843 | $2.4988 | +123.72% |
| May, 2029 | $2.2634 | $2.3806 | $2.4695 | +103.91% |
| June, 2029 | $2.2431 | $2.2489 | $2.2105 | +102.08% |
| July, 2029 | $1.9068 | $1.9207 | $2.177 | +71.78% |
| August, 2029 | $1.9878 | $1.9333 | $1.9681 | +79.08% |
| September, 2029 | $1.9432 | $1.9462 | $1.9487 | +75.06% |
| October, 2029 | $2.0003 | $1.9895 | $1.9893 | +80.21% |
| November, 2029 | $1.9357 | $1.9443 | $1.9513 | +74.39% |
| December, 2029 | $1.8476 | $1.8487 | $1.8691 | +66.45% |
Alzamend Neuro Inc Stock (ALZN) Price Forecast for 2030
Alzamend Neuro Inc Stock (ALZN) is expected to reach an average price of $2.899 in 2030, with a high forecast of $5.4247 and a low forecast of $0.3733. This signifies an +161.17% surge from the last price of $1.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.225 | $0.4835 | $1.8139 | -79.73% |
| February, 2030 | $0.7381 | $0.7348 | $0.6581 | -33.51% |
| March, 2030 | $0.7511 | $0.8186 | $0.7579 | -32.33% |
| April, 2030 | $0.7342 | $0.7544 | $0.6942 | -33.86% |
| May, 2030 | $0.5444 | $0.5805 | $0.6375 | -50.95% |
| June, 2030 | $0.2836 | $0.4236 | $0.4938 | -74.45% |
| July, 2030 | $0.5004 | $0.3733 | $0.4799 | -54.92% |
| August, 2030 | $5.0059 | $0.4665 | $4.6359 | +350.98% |
| September, 2030 | $5.1355 | $5.1455 | $4.8357 | +362.66% |
| October, 2030 | $5.335 | $5.2751 | $5.3243 | +380.63% |
| November, 2030 | $4.8446 | $5.4849 | $5.4247 | +336.45% |
| December, 2030 | $5.4242 | $5.5244 | $5.2544 | +388.67% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):